Here are four investments from Kaiser Permanente Ventures:
- Kaiser Permanente Ventures joined in a $75 million series C funding round for the digital patient booking platform DexCare.
- The health system’s venture capital arm participated with Cigna in a $34 million round for NOCD, a company that offers virtual care for obsessive-compulsive disorder.
- In November 2022, Kaiser led a $12 million funding round for remote care company Validic.
- In September 2022, Kaiser joined in on a $75 million funding round for Kate Farms, which produces plant-based nutritional products for tube or oral feeding.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.